Hsbc Holdings PLC Decreases Stake in Chemed Corporation $CHE

Key Points

• HSBC Holdings PLC reduced its stake in Chemed by 69.7% in the fourth quarter, selling 11,265 shares and ending with 4,898 shares valued at about $2.1 million.
• Chemed reported quarterly earnings of $5.65 per share, beating analyst expectations, while revenue came in slightly below forecasts at $657.5 million. The company also raised FY 2026 guidance to 24.00–24.75 EPS.
• The stock recently traded near its 52-week high, and analysts currently rate Chemed as Hold overall with an average price target of $480.25. Chemed also pays a quarterly dividend of $0.60 per share, or $2.40 annually.

Hsbc Holdings PLC cut its stake in Chemed Corporation (NYSE:CHE - Free Report) by 69.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,898 shares of the company's stock after selling 11,265 shares during the period. Hsbc Holdings PLC's holdings in Chemed were worth $2,098,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CHE. SG Americas Securities LLC grew its holdings in shares of Chemed by 773.5% during the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company's stock valued at $11,324,000 after buying an additional 23,436 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Chemed by 14.5% in the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company's stock worth $14,985,000 after acquiring an additional 4,430 shares during the last quarter. Abacus FCF Advisors LLC acquired a new stake in Chemed during the 4th quarter worth about $5,935,000. TD Asset Management Inc lifted its position in Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock worth $138,860,000 after acquiring an additional 22,715 shares during the period. Finally, C WorldWide Group Holding A S purchased a new stake in Chemed during the 4th quarter valued at about $2,189,000. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Stock Performance

Shares of CHE traded down $2.70 during mid-day trading on Friday, reaching $487.76. The company had a trading volume of 143,289 shares, compared to its average volume of 193,784. The stock has a market capitalization of $6.47 billion, a P/E ratio of 26.58, a PEG ratio of 1.80 and a beta of 0.52. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $493.47. The stock has a 50 day moving average of $443.16 and a two-hundred day moving average of $428.70. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million during the quarter, compared to analysts' expectations of $659.22 million. During the same period last year, the business earned $5.63 earnings per share. Chemed's quarterly revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, analysts expect that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed's payout ratio is 13.08%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company's stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CHE shares. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a report on Monday, June 8th. Zacks Research upgraded Chemed from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, April 29th. Royal Bank Of Canada raised their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a research report on Monday, April 27th. Finally, Bank of America lifted their price objective on shares of Chemed from $450.00 to $510.00 and gave the company a "neutral" rating in a research note on Thursday. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $480.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.